We are live on ! Find out more
PYXS icon

Pyxis Oncology
PYXS

80 hedge funds and large institutions have $93.1M invested in Pyxis Oncology in 2024 Q2 according to their latest regulatory filings, with 25 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

9,133% more call options, than puts

Call options by funds: $1.66M | Put options by funds: $18K

56% more first-time investments, than exits

New positions opened: 25 | Existing positions closed: 16

11% more funds holding

Funds holding: 72 → 80 (+8)

8.29% more ownership

Funds ownership: 39.48% → 47.77% (+8.3%)

5% more repeat investments, than reductions

Existing positions increased: 21 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5% less capital invested

Capital invested by funds: $97.8M → $93.1M (-$4.7M)

Holders
80
Holders Change
+8
Holders Change %
+11.11%
% of All Funds
1.16%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
25
Increased
21
Reduced
20
Closed
16
Calls
$1.66M
Puts
$18K
Net Calls
+$1.64M
Net Calls Change
+$1.3M

Top Buyers

1
BlackRock
BlackRock
New York
+$10.4M
2
BOCH
Blue Owl Capital Holdings
New York
+$4.4M
3
Millennium Management
Millennium Management
New York
+$3.17M
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.89M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.77M

Top Sellers

1
SC
Stempoint Capital
New York
-$2.49M
2
MIM
Monashee Investment Management
Massachusetts
-$1.89M
3
Goldman Sachs
Goldman Sachs
New York
-$923K
4
HF
HRT Financial
New York
-$592K
5
Jane Street
Jane Street
New York
-$589K
Name Holding Trade Value Shares
Change 		Change in
Stake
ECM
26
ExodusPoint Capital Management
New York
$379K +$105K +24,916 +28%
P8IP
27
Pier 88 Investment Partners
California
$376K +$262K +62,340 +121%
Renaissance Technologies
28
Renaissance Technologies
New York
$321K -$215K -51,064 -35%
Two Sigma Investments
29
Two Sigma Investments
New York
$317K +$402K +95,703 New
Morgan Stanley
30
Morgan Stanley
New York
$273K +$164K +39,084 +90%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$271K -$83.6K -19,876 -20%
YF
32
Yu Fan
$229K – – –
Qube Research & Technologies (QRT)
33
Qube Research & Technologies (QRT)
United Kingdom
$225K -$357K -84,994 -56%
RhumbLine Advisers
34
RhumbLine Advisers
Massachusetts
$216K +$274K +65,287 New
CCC
35
Cable Car Capital
California
$204K – – –
American Century Companies
36
American Century Companies
Missouri
$193K +$87.9K +20,901 +56%
SFI
37
Susquehanna Fundamental Investments
Pennsylvania
$189K -$107K -25,422 -31%
Man Group
38
Man Group
United Kingdom
$175K -$396K -94,226 -64%
UOC
39
University of Chicago
Illinois
$161K – – –
Bank of America
40
Bank of America
North Carolina
$148K +$63.4K +15,069 +51%
SC
41
Schulhoff & Co
Ohio
$139K +$84.1K +20,000 +91%
Simplex Trading
42
Simplex Trading
Illinois
$134K +$171K +40,756 New
XT
43
XTX Topco
Cayman Islands
$120K -$124K -29,572 -45%
Jane Street
44
Jane Street
New York
$117K -$589K -140,043 -80%
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$103K +$131K +31,200 New
Royal Bank of Canada
46
Royal Bank of Canada
Ontario, Canada
$100K +$19.3K +4,593 +18%
Cetera Investment Advisers
47
Cetera Investment Advisers
Illinois
$93K -$5.25K -1,250 -4%
CF
48
Corebridge Financial
Texas
$87.2K +$110K +26,273 New
Invesco
49
Invesco
Georgia
$73.2K +$92.9K +22,103 New
Wells Fargo
50
Wells Fargo
California
$73K +$89.2K +21,208 +2,543%
1
2
3 4

PYXS Hedge Fund Activity: Q2 2024 in Review

80 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Pyxis Oncology (PYXS) for Q2 2024, worth a combined $93.1M — down 4.8% from $97.8M a quarter earlier.

Buyers outnumbered sellers: 25 funds opened new PYXS positions and 16 closed out — a net gain of 9 holders — while 21 added to existing stakes and 20 trimmed.

The largest buyer was BlackRock, adding an estimated $10.4M. The largest seller was Stempoint Capital, cutting an estimated $2.49M.

  • 80 institutional investors held Pyxis Oncology (PYXS) as of Q2 2024, up from 72 in Q1 2024.
  • Funds reported $93.1M of Pyxis Oncology stock for Q2 2024, down 4.8% quarter-over-quarter.
  • 25 funds opened new Pyxis Oncology positions in Q2 2024 and 16 closed out, a net change of +9 holders.
  • The largest Pyxis Oncology buyer in Q2 2024 was BlackRock, an estimated $10.4M added.
  • The largest Pyxis Oncology seller in Q2 2024 was Stempoint Capital, an estimated $2.49M sold.

Based on aggregated 13F filings for Q2 2024.